SEC FORM 3/A

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

HOLT PAUL

(Last)

(First)

(Middle)

C/O NANTHEALTH, INC.

9920 JEFFERSON BLVD.

(Street)

CULVER CITY

90232

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/01/2016

3. Issuer Name and Ticker or Trading Symbol
NantHealth, Inc. [ NH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)
06/01/2016

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Phantom Units	⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	Common Stock	113,659	⁽³⁾	D
Phantom Units	⁽¹⁾⁽⁴⁾	⁽¹⁾⁽⁴⁾	Common Stock	31,795	⁽³⁾	D

Explanation of Responses:

1. The original filed form 3 reported an incorrect vesting schedule. This vesting schedule was also incorrectly reported on a Form 4 filed on June 9, 2016.

2. Subject to the reporting person's continuing service, one-half (1/2) of the phantom units held by the reporting person shall vest on the June 7, 2016 (the "Vesting Commencement Date"), and the remaining phantom units held by the reporting person shall vest in equal amounts each year on the same day of the month as the Vesting Commencement Date, such that the phantom units shall fully vest into shares of common stock on the fourth (4th) anniversary of the Vesting Commencement Date.

3. Each phantom unit is the economic equivalent of one share of NantHealth, Inc. common stock.

4. Subject to the reporting person's continuing service, one-half (1/2) of the phantom units held by the reporting person shall vest on the June 7, 2016, and the remaining phantom units held by the reporting person shall vest in equal amounts each year beginning on May 1, 2017, such that the phantom units shall fully vest into shares of common stock on May 1, 2020.

Remarks:

	/s/ Charles Kim as Attorney-in-Fact	08/25/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.